Search Results - "Bradley, Heath L."

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells by Metts, Jonathan, Bradley, Heath L., Wang, Zhengqi, Shah, Neil P., Kapur, Reuben, Arbiser, Jack L., Bunting, Kevin D.

    Published in Scientific reports (30-06-2017)
    “…Aberrant cytokine signaling initiated from mutant receptor tyrosine kinases (RTKs) provides critical growth and survival signals in high risk acute myeloid…”
    Get full text
    Journal Article
  2. 2

    Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia by Wang, Zhengqi, Mi, Tian, Bradley, Heath L., Metts, Jonathan, Sabnis, Himalee, Zhu, Wandi, Arbiser, Jack, Bunting, Kevin D.

    Published in Antioxidants (15-06-2021)
    “…Acute myeloid leukemia (AML) is a heterogeneous disease with a high relapse rate. Cytokine receptor targeted therapies are therapeutically attractive but are…”
    Get full text
    Journal Article
  3. 3

    Metagenomic Sequencing To Detect Respiratory Viruses in Persons under Investigation for COVID-19 by Babiker, Ahmed, Bradley, Heath L, Stittleburg, Victoria D, Ingersoll, Jessica M, Key, Autum, Kraft, Colleen S, Waggoner, Jesse J, Piantadosi, Anne

    Published in Journal of clinical microbiology (17-12-2020)
    “…Broad testing for respiratory viruses among persons under investigation (PUIs) for SARS-CoV-2 has been performed inconsistently, limiting our understanding of…”
    Get full text
    Journal Article
  4. 4

    Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells by Bradley, Heath L., Hawley, Teresa S., Bunting, Kevin D.

    Published in Blood (01-12-2002)
    “…Secreted growth factors are integral components of the bone marrow (BM) niche and can regulate survival, proliferation, and differentiation of committed…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Increased numbers of committed myeloid progenitors but not primitive hematopoietic stem/progenitors in mice lacking STAT6 expression by Bunting, Kevin D., Yu, Wen‐Mei, Bradley, Heath L., Haviernikova, Eleonora, Kelly‐Welch, Ann E., Keegan, Achsah D., Qu, Cheng‐Kui

    Published in Journal of leukocyte biology (01-08-2004)
    “…Signal transducer and activator of transcription‐6 (STAT6) plays important roles in cytokine signaling via interleukin‐4 and ‐13 receptors (IL‐4R and IL‐13R)…”
    Get full text
    Journal Article
  8. 8

    Capillary nano-immunoassay for Akt 1/2/3 and 4EBP1 phosphorylation in acute myeloid leukemia by Sabnis, Himalee, Bradley, Heath L, Bunting, Silvia T, Cooper, Todd M, Bunting, Kevin D

    Published in Journal of translational medicine (12-06-2014)
    “…Overall cure rates in acute myeloid leukemia (AML) continue to range between 60-65% with disease relapse being a major cause of mortality. The PI3K-Akt-mTOR…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Hematopoietic reconstitution with androgenetic and gynogenetic stem cells by Eckardt, Sigrid, Leu, N Adrian, Bradley, Heath L, Kato, Hiromi, Bunting, Kevin D, McLaughlin, K John

    Published in Genes & development (15-02-2007)
    “…Parthenogenetic embryonic stem (ES) cells with two oocyte-derived genomes (uniparental) have been proposed as a source of autologous tissue for…”
    Get full text
    Journal Article
  11. 11

    Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5 by Bunting, Kevin D., Bradley, Heath L., Hawley, Teresa S., Moriggl, Richard, Sorrentino, Brian P., Ihle, James N.

    Published in Blood (15-01-2002)
    “…Signal transducers and activators of transcription (STATs) are intracellular mediators of cytokine receptor signals. Because many early-acting growth factors…”
    Get full text
    Journal Article
  12. 12

    Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness by Bradley, Heath L., Couldrey, Christine, Bunting, Kevin D.

    Published in Blood (15-04-2004)
    “…Signal transducer and activator of transcription-5 (STAT5) plays an important role in repopulating activity of hematopoietic stem cells (HSCs). However, the…”
    Get full text
    Journal Article
  13. 13

    A STAT5 modifier locus on murine chromosome 7 modulates engraftment of hematopoietic stem cells during steady-state hematopoiesis by Couldrey, Christine, Bradley, Heath L., Bunting, Kevin D.

    Published in Blood (15-02-2005)
    “…Homologous disruption of expression of signal transducer and activator of transcription 5a (STAT5a) and STAT5b (STAT5ab–/–) in mice results in hematopoietic…”
    Get full text
    Journal Article
  14. 14

    Nanoproteomic assays on hematopoietic stem cells by Bradley, Heath L, Sabnis, Himalee, Pritchett, Deborah, Bunting, Kevin D

    “…Dysregulation of cytokine signaling pathways is associated with benign and malignant hematologic disorders. Improvements in therapy rely on understanding the…”
    Get more information
    Journal Article
  15. 15

    Tissue inhibitor of matrix metalloproteinase-1 overexpression in M1 myeloblasts impairs IL-6-induced differentiation by HAVIERNIK, Peter, LAHODA, Carisa, BRADLEY, Heath L, HAWLEY, Teresa S, RAMEZANI, Ali, HAWLEY, Robert G, STETLER-STEVENSON, Maryalice, STETLER-STEVENSON, William G, BUNTING, Kevin D

    Published in Oncogene (09-12-2004)
    “…The balance between matrix metalloproteinase (MMP) and tissue inhibitor of matrix metalloproteinase (TIMP) is important for extracellular matrix interactions…”
    Get full text
    Journal Article
  16. 16

    64. Metagenomic Sequencing to Identify Alternative Infections and Co-infections in Persons Under Investigation for covid-19 by Babiker, Ahmed, Bradley, Heath L, Stittleburg, Victoria D, Key, Autum, Kraft, Colleen, Waggoner, Jesse, Piantadosi, Anne

    Published in Open forum infectious diseases (31-12-2020)
    “…Abstract Background Broad testing for respiratory viruses among persons under investigation (PUI) for SARS-CoV-2 is performed inconsistently, limiting our…”
    Get full text
    Journal Article
  17. 17

    Imipramine Blue Sensitively and Selectively Targets FLT3 and c-Kit Mutant Acute Myeloid Leukemia by Metts, Jonathan L., Bradley, Heath L., Shah, Neil P., Kapur, Reuben, Arbiser, Jack L., Bunting, Kevin D.

    Published in Blood (03-12-2015)
    “…Acute myeloid leukemia (AML) is the most common acute leukemia in adults and the 2nd most common in children. Despite advances in our understanding of AML…”
    Get full text
    Journal Article
  18. 18

    Synergistic Cytotoxicity in Acute Myeloid Leukemia By Combined Treatment with Metformin and 6-Benzylthioinosine by Sabnis, Himalee S., Tripathi, Shweta, Bradley, Heath L, Yu, Wen-Mei, Tse, William, Qu, Cheng-Kui, Bunting, Kevin D.

    Published in Blood (06-12-2014)
    “…Background: Cytogenetic and molecular aberrations have improved risk stratification of acute myeloid leukemia (AML) patients, however survival continues to be…”
    Get full text
    Journal Article